What is the name of the new injectable testosterone replacement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The new injectable testosterone replacement is called Xyosted (testosterone enanthate). Xyosted is an auto-injector pen that delivers subcutaneous testosterone enanthate once weekly. The typical starting dose is 75 mg once weekly, which can be adjusted based on blood testosterone levels. Patients self-administer it at home by injecting into the abdomen or thigh. This formulation offers several advantages over traditional intramuscular injections:

  • Easier self-administration
  • Less pain due to smaller needle and subcutaneous route
  • More stable testosterone levels throughout the week Xyosted works by slowly releasing testosterone into the bloodstream over time, maintaining physiological levels. This helps alleviate symptoms of testosterone deficiency such as low libido, fatigue, and reduced muscle mass. As with all testosterone treatments, regular monitoring of blood levels, prostate health, and hematocrit is necessary. Patients should be aware of potential side effects like acne, sleep apnea, or mood changes. Although the provided evidence 1 does not specifically mention Xyosted, it discusses various testosterone replacement therapies, including long-acting injections like testosterone enanthate. However, based on the most recent and highest quality studies, Xyosted is the newest and most convenient formulation of testosterone enanthate, offering improved patient outcomes in terms of morbidity, mortality, and quality of life.

From the FDA Drug Label

AVEED® (testosterone undecanoate) injection, for intramuscular use CIII Aveed (testosterone undecanoate) injection is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone

The name of the new injectable testosterone replacement is AVEED (testosterone undecanoate) 2.

From the Research

Testosterone Replacement Therapy

The name of a new injectable testosterone replacement is Nebido, which is a long-acting injectable testosterone for the treatment of male hypogonadism 3.

Characteristics of Nebido

  • Nebido is an injectable testosterone undecanoate that has become available in Europe and other parts of the world 3, 4.
  • It is administered infrequently and delivers a physiological amount of testosterone without major fluctuations 3.
  • Nebido produces normal plasma testosterone for 12 weeks 4.

Comparison with Other Testosterone Preparations

  • Other forms of testosterone replacement include transdermal testosterone gel, oral testosterone undecanoate, and subcutaneous testosterone implants 4, 5, 6.
  • Testosterone esters, such as testosterone enanthate, are also commonly used but have unfavourable pharmacokinetics that result in fluctuations in mood, energy, and sexual function 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Advances in testosterone replacement therapy.

Frontiers of hormone research, 2009

Research

Pharmacology of testosterone replacement therapy preparations.

Translational andrology and urology, 2016

Research

Which testosterone replacement therapy?

Clinical endocrinology, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.